HC Wainwright & Co. Maintains Buy on Annexon, Raises Price Target to $25

10/19/2026
Impact: 75
Healthcare

HC Wainwright & Co. analyst Ananda Ghosh has maintained a Buy rating on Annexon (NASDAQ: ANNX) and raised the price target from $14 to $25. This adjustment reflects a positive outlook for the company's stock performance.

AI summary, not financial advice

Share: